Skip to content
CNS Clinical Research

Pennsylvania

CNS clinical trials in Pennsylvania

162 CNS studies are recruiting participants at sites in 42 cities across Pennsylvania as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 520-7418
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Browse Pennsylvania by city

Cities with the most studies recruiting right now.

Every Pennsylvania city with a recruiting study

By research area: Depression (65), Parkinson's Disease (31), Epilepsy (19), Schizophrenia (13), ADHD (11), Migraine (10), Multiple Sclerosis (10), Bipolar Disorder (3).

Philadelphia (97), Pittsburgh (56), Hershey (7), Allentown (5), Bethlehem (4), Scottdale (4), Smithfield (4), Lancaster (3), West Chester (3), Harrisburg (2), Lewisburg (2), Malvern (2), University Park (2), Willow Grove (2), Abington (1), Butler (1), Carlisle (1), Chambersburg (1), Danville (1), Dickson City (1), Ephrata (1), Erie (1), Farrell (1), Gettysburg (1), Greensburg (1), Hazleton (1), Johnstown (1), Lebanon (1), Meadowbrook (1), Mechanicsburg (1), Media (1), Monroeville (1), Moosic (1), Mount Pleasant (1), N. Huntingdon (1), New Castle (1), Philadephia (1), Pottsville (1), State College (1), West Reading (1), Wilkes-Barre (1), York (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Depression: recently updated in Pennsylvania

Basic details from each study's public record (the 12 most recently updated of 162). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Postpartum Care in the NICU (PeliCaN) Transitions

    • No phase
    • Ages 16 and older
    • Female participants
    Sponsor
    University of Pennsylvania
    Recruiting in
    Philadelphia
    Registry record
    NCT06521398 · updated
  2. A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

    • Phase 3
    • Ages 18 to 85
    • All sexes
    Sponsor
    Cybin IRL Limited
    Recruiting in
    Philadelphia
    Registry record
    NCT06793397 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Pennsylvania on ClinicalTrials.gov.

Schizophrenia: recently updated in Pennsylvania

  1. Exercise-based Program for Rehabilitation of Veterans With Severe Mental Illness

    • No phase
    • Ages 18 to 70
    • All sexes
    Sponsor
    VA Office of Research and Development
    Recruiting in
    Pittsburgh
    Registry record
    NCT05157620 · updated

Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Pennsylvania on ClinicalTrials.gov.

Bipolar disorder: recently updated in Pennsylvania

  1. Examining Neurobiological Mechanisms Underlying the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder (BD)

    • No phase
    • Ages 18 to 40
    • All sexes
    Sponsor
    University of Pittsburgh
    Recruiting in
    Pittsburgh
    Registry record
    NCT06081426 · updated

Source: ClinicalTrials.gov. Data processed . See every bipolar disorder study recruiting in Pennsylvania on ClinicalTrials.gov.

ADHD: recently updated in Pennsylvania

  1. The Myelin Disorders Biorepository Project

    • Observational
    • All ages
    • All sexes
    Sponsor
    Children's Hospital of Philadelphia
    Recruiting in
    Philadelphia · Pittsburgh
    Registry record
    NCT03047369 · updated

Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Pennsylvania on ClinicalTrials.gov.

Parkinson's disease: recently updated in Pennsylvania

  1. DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

    • Phase 3
    • Ages 18 and older
    • Female participants
    Sponsor
    AstraZeneca
    Recruiting in
    Philadelphia · Pittsburgh
    Registry record
    NCT06989112 · updated
  2. Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Pittsburgh
    Registry record
    NCT06469944 · updated
  3. Deep Brain Stimulation (DBS) Retrospective Outcomes Study

    • Observational
    • All ages
    • All sexes
    Sponsor
    Boston Scientific Corporation
    Recruiting in
    Pittsburgh
    Registry record
    NCT03664609 · updated
  4. A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Lancaster
    Registry record
    NCT06345729 · updated

Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Pennsylvania on ClinicalTrials.gov.

Multiple sclerosis (MS): recently updated in Pennsylvania

  1. Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Pittsburgh
    Registry record
    NCT03816345 · updated

Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Pennsylvania on ClinicalTrials.gov.

Epilepsy: recently updated in Pennsylvania

  1. Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Rapport Therapeutics Inc.
    Recruiting in
    Philadelphia
    Registry record
    NCT07563881 · updated

Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Pennsylvania on ClinicalTrials.gov.

Migraine: recently updated in Pennsylvania

  1. Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

    • Phase 4
    • Ages 18 to 70
    • All sexes
    Sponsor
    Mayo Clinic
    Recruiting in
    Philadelphia
    Registry record
    NCT06972056 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Pennsylvania on ClinicalTrials.gov.

Ask about studies in Pennsylvania

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 520-7418

or send a short form

How should we reach you?

Call